Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines flag Philippines · Delayed Price · Currency is PHP
1.370
+0.100 (7.87%)
At close: Nov 17, 2026

PSE:EURO Income Statement

Millions PHP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,1366,8685,7965,2644,2243,587
Revenue Growth
6.40%18.50%10.11%24.62%17.75%-6.31%
Cost of Revenue
4,5754,4293,7853,3702,7312,150
Gross Profit
2,5612,4392,0121,8941,4931,438
Selling, General & Admin
1,5981,5041,3121,2091,025991.39
Other Operating Expenses
13.5136.0530.5832.7528.0335.23
Operating Expenses
1,6111,5401,3431,2421,0531,027
Operating Income
950.33899.65669.03652.58440.44411.1
Interest Expense
-150.77-300.69-307.78-270.45-206.8-213.19
Interest & Investment Income
5.015.822.931.290.50.7
Currency Exchange Gain (Loss)
3.363.2913.341.6634.36-16.98
Other Non Operating Income (Expenses)
-147.31-16.6237.480.0912.885.85
EBT Excluding Unusual Items
660.61591.46414.99385.17281.39187.48
Gain (Loss) on Sale of Investments
45.6445.6422.4713.23-1.0943.93
Pretax Income
706.25637.1437.46398.4280.3231.41
Income Tax Expense
180.37166.899.78108.4580.4162.36
Net Income
525.88470.3337.68289.95199.89169.05
Net Income to Common
525.88470.3337.68289.95199.89169.05
Net Income Growth
33.53%39.27%16.46%45.05%18.25%-19.52%
Shares Outstanding (Basic)
4,2094,1124,1124,1124,1124,112
Shares Outstanding (Diluted)
4,2094,1124,1124,1124,1124,112
Shares Change
0.98%-----
EPS (Basic)
0.120.110.080.070.050.04
EPS (Diluted)
0.120.110.080.070.050.04
EPS Growth
32.20%37.50%13.46%45.05%21.52%-20.00%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
920.57702.7850.7362.2659.35202.83
Free Cash Flow Per Share
0.220.170.010.010.010.05
Dividend Per Share
--0.0700.0600.0350.020
Dividend Growth
--16.67%71.43%75.00%33.33%
Gross Margin
35.89%35.52%34.71%35.98%35.35%40.08%
Operating Margin
13.32%13.10%11.54%12.40%10.43%11.46%
Profit Margin
7.37%6.85%5.83%5.51%4.73%4.71%
Free Cash Flow Margin
12.90%10.23%0.88%1.18%1.41%5.65%
EBITDA
1,1851,225928.42890.72664.09639
EBITDA Margin
16.61%17.84%16.02%16.92%15.72%17.81%
D&A For EBITDA
234.93325.32259.39238.14223.65227.9
EBIT
950.33899.65669.03652.58440.44411.1
EBIT Margin
13.32%13.10%11.54%12.40%10.43%11.46%
Effective Tax Rate
25.54%26.18%22.81%27.22%28.69%26.95%